Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

20 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Identifying SARS-CoV-2 'memory' NK cells from COVID-19 convalescent donors for adoptive cell therapy.
Herrera L, Martin-Inaraja M, Santos S, Inglés-Ferrándiz M, Azkarate A, Perez-Vaquero MA, Vesga MA, Vicario JL, Soria B, Solano C, De Paz R, Marcos A, Ferreras C, Perez-Martinez A, Eguizabal C. Herrera L, et al. Among authors: azkarate a. Immunology. 2022 Feb;165(2):234-249. doi: 10.1111/imm.13432. Epub 2021 Dec 2. Immunology. 2022. PMID: 34775592 Free PMC article. Clinical Trial.
Uneven metabolic and lipidomic profiles in recovered COVID-19 patients as investigated by plasma NMR metabolomics.
Bizkarguenaga M, Bruzzone C, Gil-Redondo R, SanJuan I, Martin-Ruiz I, Barriales D, Palacios A, Pasco ST, González-Valle B, Laín A, Herrera L, Azkarate A, Vesga MA, Eguizabal C, Anguita J, Embade N, Mato JM, Millet O. Bizkarguenaga M, et al. Among authors: azkarate a. NMR Biomed. 2022 Feb;35(2):e4637. doi: 10.1002/nbm.4637. Epub 2021 Oct 27. NMR Biomed. 2022. PMID: 34708437 Free PMC article.
External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry.
Jimenez-Fonseca P, Carmona-Bayonas A, Martinez-Torron A, Alsina M, Custodio A, Serra O, Cacho Lavin D, Limón ML, Sauri T, López F, Visa L, Granja M, Martínez Lago N, Arrazubi V, Vidal Tocino R, Hernandez R, Aguado G, Cano JM, Martín Carnicero A, Mangas M, Pimentel P, Fernández Montes A, Macias Declara I, Longo F, Ramchandani A, Martín Richard M, Hurtado A, Azkarate A, Hernández Pérez C, Serrano R, Gallego J; AGAMENON-SEOM study group. Jimenez-Fonseca P, et al. Among authors: azkarate a. Ther Adv Med Oncol. 2021 Jun 17;13:17588359211019672. doi: 10.1177/17588359211019672. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 34211587 Free PMC article.
Is advanced esophageal adenocarcinoma a distinct entity from intestinal subtype gastric cancer? Data from the AGAMENON-SEOM Registry.
Alvarez-Manceñido F, Jimenez-Fonseca P, Carmona-Bayonas A, Arrazubi V, Hernandez R, Cano JM, Custodio A, Pericay Pijaume C, Aguado G, Martínez Lago N, Sánchez Cánovas M, Cacho Lavin D, Visa L, Martinez-Torron A, Arias-Martinez A, López F, Limón ML, Vidal Tocino R, Fernández Montes A, Alsina M, Pimentel P, Reguera P, Martín Carnicero A, Ramchandani A, Granja M, Azkarate A, Martín Richard M, Serra O, Hernández Pérez C, Hurtado A, Gil-Negrete A, Sauri T, Morales Del Burgo P, Gallego J. Alvarez-Manceñido F, et al. Among authors: azkarate a. Gastric Cancer. 2021 Jul;24(4):926-936. doi: 10.1007/s10120-021-01169-6. Epub 2021 Mar 2. Gastric Cancer. 2021. PMID: 33651195
Detection of the EGFR G719S Mutation in Non-small Cell Lung Cancer Using Droplet Digital PCR.
Esteva-Socias M, Enver-Sumaya M, Gómez-Bellvert C, Guillot M, Azkárate A, Marsé R, Sastre Ú, Blasco A, Calabuig-Fariñas S, Asensio VJ, Terrasa J, Obrador-Hevia A. Esteva-Socias M, et al. Among authors: azkarate a. Front Med (Lausanne). 2020 Nov 13;7:594900. doi: 10.3389/fmed.2020.594900. eCollection 2020. Front Med (Lausanne). 2020. PMID: 33282894 Free PMC article.
External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?
Jimenez-Fonseca P, Carmona-Bayonas A, Martínez de Castro E, Custodio A, Pericay Pijaume C, Hernandez R, Aguado G, Castro Unanua N, Cano JM, López F, Garrido M, Fernández Montes A, Visa L, Sánchez Cánovas M, Limón ML, Martínez Lago N, Pimentel P, Hurtado A, Azkárate A, Longo F, Diez M, Arias-Martinez A, Sauri T, Martín Carnicero A, Mangas M, Martín Richard M, Granja M, Ramchandani A, Hernández Pérez C, Cerdá P, Gil-Negrete A, Calvo M, Vidal Tocino R, Gallego J. Jimenez-Fonseca P, et al. Among authors: azkarate a. Gastric Cancer. 2021 Mar;24(2):445-456. doi: 10.1007/s10120-020-01116-x. Epub 2020 Sep 24. Gastric Cancer. 2021. PMID: 32970266 Free PMC article.
Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry.
Cotes Sanchís A, Gallego J, Hernandez R, Arrazubi V, Custodio A, Cano JM, Aguado G, Macias I, Lopez C, López F, Visa L, Garrido M, Martínez Lago N, Fernández Montes A, Limón ML, Azkárate A, Pimentel P, Reguera P, Ramchandani A, Cacho JD, Martín Carnicero A, Granja M, Martín Richard M, Hernández Pérez C, Hurtado A, Serra O, Buxo E, Vidal Tocino R, Jimenez-Fonseca P, Carmona-Bayonas A. Cotes Sanchís A, et al. Among authors: azkarate a. PLoS One. 2020 Jul 31;15(7):e0235848. doi: 10.1371/journal.pone.0235848. eCollection 2020. PLoS One. 2020. PMID: 32735623 Free PMC article.
Detection of MET Alterations Using Cell Free DNA and Circulating Tumor Cells from Cancer Patients.
Mondelo-Macía P, Rodríguez-López C, Valiña L, Aguín S, León-Mateos L, García-González J, Abalo A, Rapado-González O, Suárez-Cunqueiro M, Díaz-Lagares A, Curiel T, Calabuig-Fariñas S, Azkárate A, Obrador-Hevia A, Abdulkader I, Muinelo-Romay L, Diaz-Peña R, López-López R. Mondelo-Macía P, et al. Among authors: azkarate a. Cells. 2020 Feb 24;9(2):522. doi: 10.3390/cells9020522. Cells. 2020. PMID: 32102486 Free PMC article.
Multistate Models: Accurate and Dynamic Methods to Improve Predictions of Thrombotic Risk in Patients with Cancer.
Carmona-Bayonas A, Jimenez-Fonseca P, Garrido M, Custodio A, Hernandez R, Lacalle A, Cano JM, Aguado G, Martínez de Castro E, Alvarez Manceñido F, Macias I, Visa L, Martín Richard M, Mangas M, Sánchez Cánovas M, Longo F, Iglesias Rey L, Martínez Lago N, Martín Carnicero A, Sánchez A, Azkárate A, Limón ML, Hernández Pérez C, Ramchandani A, Pimentel P, Cerdá P, Serrano R, Gil-Negrete A, Marín M, Hurtado A, Sánchez Bayona R, Gallego J. Carmona-Bayonas A, et al. Among authors: azkarate a. Thromb Haemost. 2019 Nov;119(11):1849-1859. doi: 10.1055/s-0039-1694012. Epub 2019 Aug 28. Thromb Haemost. 2019. PMID: 31461750
Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry.
Viúdez A, Carmona-Bayonas A, Gallego J, Lacalle A, Hernández R, Cano JM, Macías I, Custodio A, Martínez de Castro E, Sánchez A, Iglesia L, Reguera P, Visa L, Azkarate A, Sánchez-Cánovas M, Mangas M, Limón ML, Martínez-Torrón A, Asensio E, Ramchandani A, Martín-Carnicero A, Hurtado A, Cerdà P, Garrido M, Sánchez-Bayonas R, Serrano R, Jiménez-Fonseca P; AGAMENON Study Group. Viúdez A, et al. Among authors: azkarate a. Clin Transl Oncol. 2020 May;22(5):734-750. doi: 10.1007/s12094-019-02183-y. Epub 2019 Aug 5. Clin Transl Oncol. 2020. PMID: 31385226
20 results